- $680 MnWorld market, 2023
- $1.1 BnProjected, 2033
- 4.7%Growth a year (CAGR)
- 4,608Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$286 Mn
2.7% a year · 42% of the world -
2
China
$55 Mn
6.2% a year · 8% of the world -
3
Canada
$54 Mn
4.7% a year · 8% of the world -
4
Japan
$42 Mn
5.2% a year · 6.2% of the world -
5
Germany
$25 Mn
2.9% a year · 3.7% of the world -
6
France
$19 Mn
3.7% a year · 2.8% of the world -
7
UK
$18 Mn
2.7% a year · 2.6% of the world -
8
Brazil
$17 Mn
5.7% a year · 2.5% of the world -
9
Italy
$16 Mn
4.2% a year · 2.4% of the world -
10
Ecuador
$14 Mn
5.3% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainBrain Imaging, Biomarkers and NeuroInformatics by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 51,119 papers since 2021
- Subliminal beauty engages the brain's valuation circuits. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2026
- Multi-Site Quality Assurance of ADC and PDFF Measurements: A Multi-Vendor Phantom Study. Journal of magnetic resonance imaging : JMRI, 2026
- Late leptomeningeal dissemination of a primary intramedullary spinal cord melanoma after three years of control on pembrolizumab. BMJ case reports, 2026
- Age-dependent molecular and neuroimaging changes following social defeat stress in adolescent and adult rats. Neurobiology of disease, 2026
- Myelin water fraction mapping with voxelwise appraisal of solution ambiguity by globally optimized single and joint inversion of spin- and gradient-echo data. Magnetic resonance imaging, 2026
Compare Brain Imaging, Biomarkers and NeuroInformatics side by side
Key companies in Brain Imaging, Biomarkers and NeuroInformatics
Siemens Healthineers
GE Healthcare
Johnson & Johnson
Roche Diagnostics
Thermo Fisher Scientific
Abbott Laboratories
Quick answers
How big is the Brain Imaging, Biomarkers and NeuroInformatics market?
The world Brain Imaging, Biomarkers and NeuroInformatics market was worth about $680 Mn in 2023 and is projected to reach $1.1 Bn by 2033, growing 4.7% a year (CAGR).
Which country has the largest Brain Imaging, Biomarkers and NeuroInformatics market?
The US is the largest of the 24 countries we cover, at $286 Mn in 2023. India grows fastest, at 7.7% a year.
How many clinical trials are running in Brain Imaging, Biomarkers and NeuroInformatics?
ClinicalTrials.gov lists 4,608 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Brain Imaging, Biomarkers and NeuroInformatics?
PubMed lists about 51,119 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.